All news articles for December 2010

How much valerenic acid is enough?

AHPA calls for dialogue with ConsumerLab over testing methods

By Shane Starling

In the midst of a dispute over valerian product testing standards that has escalated into something far more rancorous, the American Herbal Products Association (AHPA) has called on ConsumerLab.com to seek industry counsel over those very same standards.

PepsiCo pays a high price for a gamble in Russian dairy

PepsiCo pays a high price for a gamble in Russian dairy

By Guy Montague-Jones

When PepsiCo put up $5.4bn last week to acquire Wimm-Bill-Dann, it was seduced by the promise of high revenue growth but like any high-yield investment the Russian deal does not come without risks.

Duro has been pulled from the market by its maker

Contaminated herbal Viagra withdrawn

By Shane Starling

A herbal erectile dysfunction (ED) dietary supplement has been voluntary withdrawn from the US market by its Floridian manufacturer after it was alerted to a contamination problem with the unauthorized substance, sildenafil.

A transatlantic view of regulations and health claims

A transatlantic view of regulations and health claims

By Stephen Daniells

Should the FDA work to be more like EFSA? Speaking at the NutraIngredients Health Claims 2010 conference Andrew Shao said the two organisations are already very similar in the way they review scientific claims.

Improving perceptions of oat beta glucans

Dispatches from HIE 2010

Improving perceptions of oat beta glucans

By Ben Bouckley

David Peters, head of business development at Swedish life sciences firm Biovelop discusses how his firm has worked to overcome poor perceptions of oat-based beta-glucans by improving their aesthetic and technical qualities.

Follow us

Products

View more

Webinars